UBS Group AG - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 45 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$43,224
-42.2%
11,126
-14.2%
0.00%
Q2 2023$74,791
+556.8%
12,962
+639.8%
0.00%
Q1 2023$11,388
+116.6%
1,752
-8.4%
0.00%
Q4 2022$5,258
-67.1%
1,912
-65.3%
0.00%
Q3 2022$16,000
+128.6%
5,510
+61.4%
0.00%
Q2 2022$7,000
-69.6%
3,413
+21.5%
0.00%
Q1 2022$23,000
-42.5%
2,810
-35.6%
0.00%
Q4 2021$40,000
-16.7%
4,363
+13.4%
0.00%
Q3 2021$48,000
-44.2%
3,846
-49.6%
0.00%
Q2 2021$86,000
-42.7%
7,636
-23.0%
0.00%
Q1 2021$150,000
+111.3%
9,921
+62.5%
0.00%
Q4 2020$71,000
+195.8%
6,107
+95.2%
0.00%
Q3 2020$24,000
-70.4%
3,128
-57.4%
0.00%
Q2 2020$81,000
-32.5%
7,344
-33.1%
0.00%
Q1 2020$120,000
-59.7%
10,984
-41.3%
0.00%
Q4 2019$298,000
+44.7%
18,714
+34.1%
0.00%
Q3 2019$206,000
+312.0%
13,954
+220.8%
0.00%
Q2 2019$50,000
+108.3%
4,350
+102.1%
0.00%
Q1 2019$24,000
-29.4%
2,152
-48.2%
0.00%
Q4 2018$34,000
-38.2%
4,156
+23.0%
0.00%
Q3 2018$55,000
+2650.0%
3,379
+3057.9%
0.00%
Q2 2018$2,0001070.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Perceptive Advisors 5,038,983$19,576,4480.65%
BML Capital Management, LLC 150,000$582,7500.54%
Caligan Partners LP 259,593$1,009,8170.46%
Avoro Capital Advisors LLC 2,954,064$11,476,5390.18%
Boxer Capital, LLC 166,955$648,6200.04%
SteelPeak Wealth, LLC 136,986$532,1910.03%
Legacy Trust 18,750$72,8440.02%
Miracle Mile Advisors, LLC 118,221$459,2890.01%
SPC Financial, Inc. 30,000$116,5500.01%
KORNITZER CAPITAL MANAGEMENT INC /KS 99,251$385,5900.01%
View complete list of VERRICA PHARMACEUTICALS INC shareholders